| Expert opinion on the management of patients with osteoporosis with anabolic drugs in Italy M Rossini, FP Cantatore, A Del Puente, B Frediani, D Gatti, S Giannini, ... Reumatismo 76 (2), 2024 | | 2024 |
| AB1129 PATIENTS AND PHYSICIANS TREATMENT PREFERENCES FOR SYSTEMIC LUPUS ERYTHEMATOSUS: A COMPARATIVE ANALYSIS OF COMPLEMENTARY DISCRETE CHOICE EXPERIMENTS M Piga, L Quartuccio, F Atzeni, M Callori, A Doria, G Emmi, F Franceschini, ... Annals of the Rheumatic Diseases 83 (Suppl 1), 1896-1897, 2024 | | 2024 |
| AB0526 CLINICAL AND ULTRASONOGRAPHIC REMISSION IN BIO-NAÏVE AND BIO-FAILURE RHEUMATOID ARTHRITIS PATIENTS AT 24-WEEK OF UPADACITINIB TREATMENT: THE UPARAREMUS REAL-LIFE STUDY A Picchianti-Diamanti, MS Cattaruzza, S Salemi, RDI Rosa, G Sesti, ... Annals of the Rheumatic Diseases 83 (Suppl 1), 1537-1538, 2024 | | 2024 |
| POS1021 UNSUPERVISED MACHINE-LEARNING ALGORITHM FOR THE IDENTIFICATION OF CLINICAL PHENOTYPES ACROSS PATIENTS INITIATING BELIMUMAB IN THE LUPUS ITALIAN REGISTRY (LIRE) OF THE … M Gatto, V Venerito, D Rozza, G Landolfi, CA Scirè, GD Sebastiani, ... Annals of the Rheumatic Diseases 83 (Suppl 1), 987-988, 2024 | | 2024 |
| AB0077 IMMUNOGENICITY AND SAFETY PROSPECTIVE STUDY OF ANTI-SARS-CoV-2 MRNA VACCINATION IN A REAL-LIFE SETTING OF SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS M Ferraioli, I Prevete, MS Chimenti, L De Marco, S Meschi, D Mariotti, ... Annals of the Rheumatic Diseases 83 (Suppl 1), 1268-1269, 2024 | | 2024 |
| Impact of HLA-B51 on uveitis and retinal vasculitis: data from the AIDA International Network Registries on ocular inflammatory disorders J Sota, S Guerriero, G Lopalco, A Tufan, G Ragab, I AlMaglouth, M Govoni, ... Ocular Immunology and Inflammation, 1-8, 2024 | | 2024 |
| Characteristics of emerging new autoimmune diseases after COVID‐19 vaccination: A sub‐study by the COVAD group R Shumnalieva, N Ravichandran, J Hannah, M Javaid, N Darooka, D Roy, ... International journal of rheumatic diseases 27 (5), e15178, 2024 | | 2024 |
| Management of pregnancy in autoimmune rheumatic diseases: maternal disease course, gestational and neonatal outcomes and use of medications in the prospectiveItalian P-RHEUM … L Andreoli, MC Gerardi, M Gerosa, D Rozza, F Crisafulli, R Erra, D Lini, ... RMD open 10 (2), e004091, 2024 | | 2024 |
| The Systemic Score May Identify Life‐Threatening Evolution in Still Disease: Data from the GIRRCS AOSD‐Study Group and the AIDA Network Still Disease Registry P Ruscitti, F Masedu, A Vitale, V Caggiano, I Di Cola, P Cipriani, M Valenti, ... Arthritis & Rheumatology, 2024 | | 2024 |
| Practice pattern for the use of intravenous iloprost for the treatment of peripheral vasculopathy in systemic sclerosis: A case–control study from the Italian national … V Riccieri, G Pellegrino, E Cipolletta, D Giuggioli, G Bajocchi, ... Journal of Scleroderma and Related Disorders 9 (1), 38-49, 2024 | 1 | 2024 |
| Correction: Clinical and laboratory features associated with macrophage activation syndrome in Still’s disease: data from the international AIDA Network Still’s Disease Registry P Triggianese, A Vitale, G Lopalco, HA Mayrink Giardini, F Ciccia, ... Internal and Emergency Medicine 19 (1), 255-257, 2024 | | 2024 |
| Type 1 diabetes, COVID‐19 vaccines and short‐term safety: Subgroup analysis from the global COVAD study T Chatterjee, N Ravichandran, N Nair, AE Gracia‐Ramos, B Barman, ... Journal of diabetes investigation 15 (1), 131-138, 2024 | 1 | 2024 |
| Still’s disease continuum from childhood to elderly: data from the international AIDA Network Still’s disease registry A Vitale, V Caggiano, G Lopalco, HAM Giardini, F Ciccia, IA Almaghlouth, ... RMD open 9 (4), e003578, 2023 | 4 | 2023 |
| Management of psoriatic arthritis: a consensus opinion by expert rheumatologists S D’angelo, F Atzeni, M Benucci, G Bianchi, F Cantini, RF Caporali, ... Frontiers in Medicine 10, 1327931, 2023 | 1 | 2023 |
| Older age, a high titre of neutralising antibodies and therapy with conventional DMARDs are associated with protection from breakthrough infection in rheumatoid arthritis … A Picchianti-Diamanti, A Navarra, A Aiello, B Laganà, G Cuzzi, A Salmi, ... Vaccines 11 (11), 1684, 2023 | 2 | 2023 |
| Clinical and laboratory features associated with macrophage activation syndrome in Still’s disease: data from the international AIDA Network Still’s Disease Registry P Triggianese, A Vitale, G Lopalco, HA Mayrink Giardini, F Ciccia, ... Internal and Emergency Medicine 18 (8), 2231-2243, 2023 | 1 | 2023 |
| Unfolding dermatologic spectrum of Behçet’s disease in Italy: real-life data from the International AIDA Network Behçet’s disease Registry M D’Onghia, E Cinotti, A Cartocci, A Vitale, V Caggiano, L Tognetti, ... Internal and Emergency Medicine 18 (8), 2245-2252, 2023 | 2 | 2023 |
| COVID-19 prognosis in systemic lupus erythematosus compared with rheumatoid arthritis and spondyloarthritis: results from the CONTROL-19 Study by the Italian Society for … C Scirocco, S Ferrigno, L Andreoli, M Fredi, C Lomater, L Moroni, ... Lupus Science & Medicine 10 (2), e000945, 2023 | | 2023 |
| The administration of methotrexate in patients with Still's disease,“real-life” findings from AIDA Network Still Disease Registry P Ruscitti, J Sota, A Vitale, G Lopalco, F Iannone, M Morrone, ... Seminars in arthritis and rheumatism 62, 152244, 2023 | 4 | 2023 |
| Rheumatoid factor isotypes in rheumatoid arthritis diagnosis and prognosis: a systematic review and meta-analysis F Motta, N Bizzaro, D Giavarina, F Franceschini, M Infantino, B Palterer, ... RMD open 9 (3), e002817, 2023 | 15 | 2023 |
